|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600122088 |
|
最近更新日期: Date of Last Refreshed on: |
2026-04-09 08:23:48 |
|
注册时间: Date of Registration: |
2026-04-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于颈部动态 MRI 的脊髓型颈椎病个体化手术诊疗方案的规划与实施 |
|
Public title: |
To plan and implement the individualized surgical diagnosis and treatment plan for cervical spondylotic myelopathy based on neck dynamic MRI |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于颈部动态 MRI 的脊髓型颈椎病个体化手术诊疗方案的规划与实施 |
|
Scientific title: |
To plan and implement the individualized surgical diagnosis and treatment plan for cervical spondylotic myelopathy based on neck dynamic MRI |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨世倡 |
研究负责人: |
钟远鸣 |
|
Applicant: |
YangShichang |
Study leader: |
ZhongYuanming |
|
申请注册联系人电话: Applicant telephone: |
+86 130 3281 5141 |
研究负责人电话:
Study leader's |
+86 135 0771 5643 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
3307108038@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
guoguanyang2025@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广西壮族自治区南宁市青秀区东葛路89号 |
研究负责人通讯地址: |
广西壮族自治区南宁市青秀区东葛路89号 |
|
Applicant address: |
89 Dongge Road, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region, China |
Study leader's address: |
89 Dongge Road, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region, China |
|
申请注册联系人邮政编码: Applicant postcode: |
530023 |
研究负责人邮政编码: Study leader's postcode: |
530023 |
|
申请人所在单位: |
广西中医药大学第一附属医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
广西中医药大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦审2025-080-KY-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广西中医药大学第一附属医院伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Review Committee of the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-02-06 00:00:00 | ||
|
伦理委员会联系人: |
葛老师 |
||
|
Contact Name of the ethic committee: |
Ge Lijuan |
||
|
伦理委员会联系地址: |
广西壮族自治区南宁市青秀区东葛路89号 |
||
|
Contact Address of the ethic committee: |
89 Dongge Road, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 771 562 3553 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广西中医药大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广西壮族自治区南宁市青秀区东葛路89号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
89 Dongge Road, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金委员会(项目编号:82260942) |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China (82260942) |
||||||||||||||||||||||
|
研究疾病: |
脊髓型颈椎病 |
||||||||||||||||||||||
|
Target disease: |
Cervical spondylotic myelopathy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
评估颈部动态 MRI 指导下的个体化手术诊疗方案对脊髓型颈椎病患者术后神经功能恢复(以日本骨科协会 JOA 评分为核心评价指标)的临床疗效。 |
||||||||||||||||||||||
|
Objectives of Study: |
To evaluate the clinical effect of individualized surgical diagnosis and treatment under the guidance of neck dynamic MRI on postoperative neurological recovery (Japanese Orthopaedic Association JOA score as the core evaluation index) in patients with cervical spondylotic myelopathy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1、符合脊髓型颈椎病诊断标准; 2、年龄 18-60 周岁,性别不限,生命体征平稳者; 3、病程>3 个月; 4、自愿接受对应治疗方案(观察组术前行动态 MRI,对照组术前常规 MRI); 5、治疗前 4 周无糖皮质激素用药史; 6、签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Meet the diagnostic criteria of cervical spondylotic myelopathy; 2. Age of 18-60 years old, both sexes, stable vital signs; 3. Course of disease > 3 months; 4. Voluntarily accept the corresponding treatment plan (the observation group underwent dynamic MRI before surgery, and the control group underwent conventional MRI before surgery); 5. No history of glucocorticoid use 4 weeks before treatment; 6. Signed the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
1.病历中未明确符合脊髓型颈椎病诊断标准,或基线资料(病程、影像学报告、症状记录)不完整,无法完成疗效与安全性评价者; 2.病历记录显示近 3 个月参与过其他临床研究,存在干预交叉或数据干扰可能者; 3.既往有严重颈椎创伤史、颈椎手术史或其他脊柱相关手术史(以手术记录、住院病史记载为准),影响手术方案可比性及疗效评估者; 4.病历中明确记录合并心、肝、肾等重要脏器功能严重损伤、造血功能异常或恶性肿瘤等严重基础疾病,可能增加研究偏倚或影响随访结局者; 5.有阿片类药物、镇静催眠药依赖史或长期酒精滥用史(以病历用药记录、病史自述为准),可能干扰神经功能评估者; 6.病历记录为孕妇、哺乳期女性(基于产科病史、检查记录判定); 7.治疗前 4 周病历中有糖皮质激素使用记录,可能影响神经功能或炎症反应评估,干扰疗效判定者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients who did not meet the diagnostic criteria of cervical spondylotic myelopathy in the medical record, or whose baseline data (course of disease, imaging report, symptom record) were incomplete, and the efficacy and safety evaluation could not be completed; 2. Medical records showed that they had participated in other clinical studies in the past 3 months, with intervention crossover or data interference possible; 3. patients with a history of severe cervical spine trauma, cervical spine surgery or other spine-related surgery (based on operation records and hospitalization history), which may affect the comparability of surgical programs and efficacy evaluation; 4. patients with serious underlying diseases such as heart, liver, kidney or other important organ dysfunction, hematopoietic dysfunction or malignant tumors, which may increase the study bias or affect the follow-up outcome; 5. patients with a history of dependence on opioids, sedatives and hypnotics or long-term alcohol abuse (based on the medication record or self-history), which may interfere with the assessment of neurological function; 6. pregnant or lactating women (based on obstetric history and examination records); 7. The use of glucocorticoids in the medical records for 4 weeks before treatment, which may affect the evaluation of neurological function or inflammatory response and interfere with the evaluation of efficacy; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-01-01 00:00:00至 To 2027-01-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-04-30 00:00:00 至 To 2026-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
none |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2027年02月:去除身份标识的原始研究数据将通过Figshare (https://figshare.com)公开,包括参与者的基线特征、疗效评估结果(JOA/VAS/NDI评分)、安全性记录和影像学数据相关的分析结果。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
2027 02 :De-identified original study data will be publicly available via Figshare (https://figshare.com) , including baseline characteristics of participants, efficacy assessment results (JOA/VAS/NDI scores), safety records and imaging data-related analysis results. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究为基于颈部动态 MRI 的脊髓型颈椎病个体化手术诊疗方案的规划与实施回顾性队列研究,数据采集和管理严格遵循临床研究规范,结合病例记录表(Case Record Form, CRF) 标准化设计与电子数据采集和管理系统(Electronic Data Capture, EDC) 数字化管理,确保研究数据的完整性、准确性、可追溯性 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This study was a retrospective cohort study on the planning and implementation of individualized surgical diagnosis and treatment plan for cervical spondylotic myelopathy based on cervical dynamic MRI. Data collection and management strictly followed the clinical research standards. The standardized design of Case Record Form (CRF) and the digital management of Electronic Data Capture and management system (EDC) were combined to ensure the integrity, accuracy and traceability of research data |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |